Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Notch signaling molecule important in type 2 immunity

19.10.2005


Findings may lead to new treatments for asthma and other inflammatory-related diseases


Cross-sections of the parasitic worm Trichuris in the lumen of the mouse gut (left). Trichuris lives partially embedded in host intestinal epithelial cells. Protective T helper cells secrete molecules called cytokines that induce cells in the gut to produce mucus (right, intestinal goblet cell, stained blue). This mucus production is typical of a Th2 response. In the case of the lung, this same type of response induces mucus production that contributes to breathing difficulties typically suffered during an asthma attack. The absence of this mucus response in mice lacking Notch is consistent with a role for this pathway in controlling Th2 inflammation.



Defects in immune system cells called T helper cells may lead to diseases characterized by a faulty inflammatory response such as autoimmunity and asthma. Understanding the molecular steps involved in how T helper cells mature may help researchers develop treatments for these diseases.

Helper T cells differentiate into two different types of cells –Th1 or Th2 – which are responsible for regulating immunity to different types of pathogens. Now, researchers at the University of Pennsylvania School of Medicine have shed light on a key molecular switch in this differentiation.


Notch is a protein that is a critical regulator of the process by which stem and other multipotent cells take on a specialized function, such as a T lymphocyte or a nerve cell in organisms ranging from fruitflies to humans. Using mice in which Notch signaling could be induced to turn off in mature T cells, the researchers showed that Notch signaling is an important determinant of whether an organism can mount an effective Th2 response. The mice lacking Notch signaling were unable to mount a protective Th2 cell response against infection by the gastrointestinal parasitic worm Trichuris muris. However, the mice did mount a healthy Th1 response to an infection by the intracellular parasite Leishmania major, showing that Notch signaling is specifically required for the Th2 arm of the immune system.

These findings indicate that regulating Notch signaling may have a therapeutic role in treating diseases caused by abnormally increased Th2 responses, such as asthma, autoimmunity, and some forms of inflammatory bowel disease. Drugs that inhibit Notch signaling, called gamma secretase inhibitors, are currently in clinical trials for T-cell leukemia and Alzheimer’s disease. This study – published in today’s issue of the Journal of Experimental Medicine – suggests that these drugs may be useful in treating diseases typified by increased Th2 responses.

Senior author Warren Pear, MD, PhD, Associate Professor of Pathology and Laboratory Medicine, was one of the original discoverers of the role of Notch signaling in T-cell development. Notch activates gene transcription in the nucleus of cells, and depending on the biochemical context, it turns certain pathways on and others off. "The potential importance of our study is that it shows that Notch signaling specifically influences Th2 immunity in a live animal when challenged with a pathogen, suggesting that drugs that inhibit Notch may be useful for treating diseases associated with a pathological Th2 response, such as asthma," says Pear. He is also a member of Penn’s Abramson Family Cancer Research Institute and The Institute for Medicine and Engineering.

Helper T cells fight many types of infectious diseases and are also the cells that regulate tolerance to self and the molecules that cause the pathogenesis of such inflammatory diseases as arthritis, inflammatory bowel disease, and asthma. Antigen-presenting cells take up pathogens and migrate to the spleen or lymph nodes, where they instruct immature T cells how to differentiate into Th1 or Th2 helper T cells, killer T cells, or other types of immune system cells.

Some of the factors that signal a T cell to become Th1 or Th2 cells are well characterized, but some are not. "The role of Notch in that decision-making has been controversial," says co-author Terry Fang, a graduate student in Penn’s Immunology Program. "And this paper weighs in on this." Some studies suggest that Notch is important for the Th1 pathway, others suggest both Th1 and Th2. This study suggests that there’s a specific requirement for Notch in Th2 differentiation only.

The specificity of Notch in regulating T-cell function is highlighted in this study. "Mice lacking Notch failed to control infection with a pathogen requiring a Th2 response, demonstrating that Notch is a critical regulator of this response," adds co-author David Artis, PhD, Assistant Professor at Penn’s School of Veterinary Medicine. "The ability of these same animals to mount strong Th1 responses demonstrates the specificity of the Notch pathway in regulating this important cell type of the immune system."

The potential clinical benefit of these new findings is that gamma secretase inhibitors may so on be available for testing in the clinics. One potential side effect of these drugs is that they inhibit other pathways besides Notch. In addition, inhibiting Notch may cause side effects because this protein is used in a wide variety of cellular processes. The new mouse model described in this paper may be particularly useful for identifying the consequences of turning Notch off in different organs, an important issue for assessing potential side effects of pharmacologic Notch inhibitors.

The current work provides the rationale for determining whether manipulating Notch signaling will be useful in combating such diseases as parasitic infections, asthma, and inflammatory bowel disease. "The exciting possibility is that therapies are available," says Pear. "The challenge, however, is determining their efficacy and safety."

Karen Kreeger | EurekAlert!
Further information:
http://www.uphs.upenn.edu

More articles from Life Sciences:

nachricht Topologische Quantenchemie
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

nachricht Topological Quantum Chemistry
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Ultrathin device harvests electricity from human motion

24.07.2017 | Power and Electrical Engineering

Scientists announce the quest for high-index materials

24.07.2017 | Materials Sciences

ADIR Project: Lasers Recover Valuable Materials

24.07.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>